Higher Diet Phytochemical Index Linked to Lower Colorectal Cancer Odds in New Case-Control Study
A hospital-based case-control study published Sept. 15, 2026, in Frontiers in Nutrition found that adults in the highest third for dietary phytochemical intake had 52% lower odds of colorectal cancer than those in the lowest third. Each one-unit rise in the researchers' phytochemical index also tracked with a 5.4% drop in colorectal cancer odds.
Researchers compared 490 patients newly diagnosed with colorectal cancer to 490 cancer-free adults, using a validated food frequency questionnaire to calculate a Dietary Phytochemical Index — the percentage of daily calories coming from phytochemical-rich foods such as vegetables, fruits, legumes and whole grains. Mean index scores were lower among the cancer patients than the controls. After adjusting for other factors, each one-unit increase in the index corresponded to 5.4% lower odds of colorectal cancer (adjusted odds ratio 0.946, 95% CI 0.909-0.984). Compared with the lowest third of eaters, the highest third had 52% lower odds (odds ratio 0.48 versus a reference odds ratio of 1, 95% CI 0.298-0.773). Blood tests also showed higher index scores lined up with lower levels of inflammatory and oxidative-stress markers.
Highest Phytochemical Intake Tertile: 52% Lower Colorectal Cancer Odds (OR 0.48)
The authors propose that phytochemicals may work through antioxidant and anti-inflammatory effects and support for the gut lining, the barrier that keeps gut contents from leaking into the bloodstream. Because blood samples were drawn after diagnosis, the researchers describe their exploratory mediation analysis linking inflammation, oxidative stress and gut barrier markers as hypothesis-generating only, not evidence that these pathways caused the lower odds.
Blood samples were drawn after the cancer diagnosis, so the biomarker patterns could reflect the disease itself rather than a cause of it, and the study cannot say whether diet changed before or after diagnosis. Funding was not reported, and absolute risk was not reported.
Data Panel
- Who
- 490 hospital patients newly diagnosed with colorectal cancer and 490 cancer-free controls; age and sex split not reported.
- Design
- Hospital-based case-control study; diet assessed by a validated food frequency questionnaire, blood biomarkers drawn after CRC diagnosis; multivariable logistic and linear regression with exploratory mediation analysis.
- Dose
- Dietary Phytochemical Index (PI): percentage of total daily calories derived from phytochemical-rich foods; exposure compared across index tertiles rather than a fixed dose.
- Primary result
- Each one-unit increase in PI was tied to 5.4% lower odds of colorectal cancer (adjusted odds ratio 0.946, 95% CI 0.909-0.984). Compared with the lowest PI tertile (reference odds ratio 1), the highest tertile had 52% lower odds (odds ratio 0.48, 95% CI 0.298-0.773).
- Secondary
- Mean PI was lower in CRC patients than in cancer-free controls. Higher PI tracked with lower blood levels of inflammatory and oxidative-stress markers. Exploratory mediation analysis suggested statistical links through inflammation, oxidative stress and gut barrier markers, but the authors call this hypothesis-generating, not evidence of cause and effect, since biomarkers were drawn after diagnosis.
- Funding / conflicts
- Not reported.
Dr. Axe's Take
A 52% difference in colorectal cancer odds between the highest and lowest thirds of plant-compound intake is a large signal, even though this case-control design can't prove diet came before the cancer. The authors treat their inflammation and oxidative-stress findings as hypothesis-generating, not proof, since blood was drawn after diagnosis rather than before. I still take it seriously: cruciferous vegetables like broccoli and cauliflower, berries and legumes carry the polyphenols and glucosinolates most often tied to these markers in other research. My move this week is to build lunch and dinner around a large serving of colorful vegetables and legumes instead of treating them as a side dish.
— Dr. Axe